SCHEMBL7224310

SCHEMBL7224310

Cc1cc(C(C)[O])c2ccccc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
NCF1 P14598 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
USP2 O75604 1/20 0.46
MAPT P10636 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HTT P42858 3/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
EDNRA P25101 2/20 0.45
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
GALR3 O60755 1/20 0.42
RAB9A P51151 1/20 0.42
ADRB2 P07550 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998749 0.85 CYP1A2 (0.60) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL7379490 0.84 CYP1A2 (0.55) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL7226133 0.81 BACE1 (0.56) CYP1A2NCF1SMN1; SMN2KMT2AKDM4E
SCHEMBL21316068 0.80 CYP1A2 (0.58) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL13991803 0.79 CYP1A2 (0.56) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL7227501 0.78 MEN1 (0.45) CYP1A2SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL19724363 0.77 NCF1 (0.56) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL3632780 0.77 CYP1A2 (0.46) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL7219738 0.76 ADORA2A (0.61) CYP1A2NCF1SMN1; SMN2MEN1KMT2A
SCHEMBL7382607 0.76 EDNRA (0.52) CYP1A2NCF1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642255-B2 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-11-04 US disclosed
US-6455522-B1 ANTIINFLAMMATORY AGENTS; AGGRECANASE AND TUMOR NECROSIS FACTOR INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-24 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed